Skip to Content

Quest PharmaTech Inc QPT

Morningstar Rating
CAD 0.03 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

QPT is trading at a 65% discount.
Price
CAD 0.03
Fair Value
CAD 3.31
Uncertainty
Extreme
1-Star Price
CAD 4.16
5-Star Price
CAD 2.63
Economic Moat
Jnb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QPT is a good fit for your portfolio.

Trading Information

Previous Close Price
CAD 0.03
Day Range
CAD 0.030.03
52-Week Range
CAD 0.020.11
Bid/Ask
CAD 0.03 / CAD 0.03
Market Cap
CAD 4.23 Mil
Volume/Avg
1 / 43,157

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
QPT
Price/Earnings (Normalized)
Price/Book Value
0.06
Price/Sales
Price/Cash Flow
Price/Earnings
QPT

Financial Strength

Metric
QPT
Quick Ratio
0.26
Current Ratio
0.26
Interest Coverage
−1,081.54
Quick Ratio
QPT

Profitability

Metric
QPT
Return on Assets (Normalized)
−1.99%
Return on Equity (Normalized)
−2.01%
Return on Invested Capital (Normalized)
−1.96%
Return on Assets
QPT
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRYbkdfxvtZbxl$570.1 Bil
VRTX
Vertex Pharmaceuticals IncLkvvbntvCthdhh$108.0 Bil
REGN
Regeneron Pharmaceuticals IncCmmgvzzgJnlppx$105.6 Bil
MRNA
Moderna IncRqnlklvRkx$40.8 Bil
ARGX
argenx SE ADRWhsdcmtQbng$23.5 Bil
BNTX
BioNTech SE ADRCjnfsffPrhr$21.9 Bil
ALNY
Alnylam Pharmaceuticals IncFzspklvtHppgbvw$18.8 Bil
BMRN
Biomarin Pharmaceutical IncBtdkpzzyMclcxy$16.5 Bil
RPRX
Royalty Pharma PLC Class AJrdxsrjhqChvhq$13.6 Bil
INCY
Incyte CorpStrgbtjcQvmspr$12.8 Bil

Sponsor Center